Alonso MJ - Search Results

1

Using nanotechnology to deliver biomolecules from nose to brain - peptides, proteins, monoclonal antibodies and RNA.

Borrajo ML, Alonso MJ. Borrajo ML, et al. Among authors: alonso mj. Drug Deliv Transl Res. 2022 Apr;12(4):862-880. doi: 10.1007/s13346-021-01086-2. Epub 2021 Nov 3. Drug Deliv Transl Res. 2022. PMID: 34731414 Free PMC article.

2

Polysaccharide colloidal particles as delivery systems for macromolecules.

Janes KA, Calvo P, Alonso MJ. Janes KA, et al. Among authors: alonso mj. Adv Drug Deliv Rev. 2001 Mar 23;47(1):83-97. doi: 10.1016/s0169-409x(00)00123-x. Adv Drug Deliv Rev. 2001. PMID: 11251247 Review.

3

The potential of chitosan for the oral administration of peptides.

Prego C, Torres D, Alonso MJ. Prego C, et al. Among authors: alonso mj. Expert Opin Drug Deliv. 2005 Sep;2(5):843-54. doi: 10.1517/17425247.2.5.843. Expert Opin Drug Deliv. 2005. PMID: 16296782 Review.

4

Hyaluronic acid/Chitosan nanoparticles as delivery vehicles for VEGF and PDGF-BB.

Parajó Y, D'Angelo I, Welle A, Garcia-Fuentes M, Alonso MJ. Parajó Y, et al. Among authors: alonso mj. Drug Deliv. 2010 Nov;17(8):596-604. doi: 10.3109/10717544.2010.509357. Drug Deliv. 2010. PMID: 20883178

5

Polymer-based oral peptide nanomedicines.

Herrero EP, Alonso MJ, Csaba N. Herrero EP, et al. Among authors: alonso mj. Ther Deliv. 2012 May;3(5):657-68. doi: 10.4155/tde.12.40. Ther Deliv. 2012. PMID: 22834409 Review.

6

Nanomedicine and cancer immunotherapy - targeting immunosuppressive cells.

Torres Andón F, Alonso MJ. Torres Andón F, et al. Among authors: alonso mj. J Drug Target. 2015;23(7-8):656-71. doi: 10.3109/1061186X.2015.1073295. J Drug Target. 2015. PMID: 26453162 Review.

7

Lymphatic Targeting of Nanosystems for Anticancer Drug Therapy.

Abellan-Pose R, Csaba N, Alonso MJ. Abellan-Pose R, et al. Among authors: alonso mj. Curr Pharm Des. 2016;22(9):1194-209. doi: 10.2174/1381612822666151216150809. Curr Pharm Des. 2016. PMID: 26675222 Review.

8

Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials.

Aguirre TA, Teijeiro-Osorio D, Rosa M, Coulter IS, Alonso MJ, Brayden DJ. Aguirre TA, et al. Among authors: alonso mj. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):223-241. doi: 10.1016/j.addr.2016.02.004. Epub 2016 Feb 24. Adv Drug Deliv Rev. 2016. PMID: 26921819 Review.

9

Lipid-based nanocarriers for oral peptide delivery.

Niu Z, Conejos-Sánchez I, Griffin BT, O'Driscoll CM, Alonso MJ. Niu Z, et al. Among authors: alonso mj. Adv Drug Deliv Rev. 2016 Nov 15;106(Pt B):337-354. doi: 10.1016/j.addr.2016.04.001. Epub 2016 Apr 11. Adv Drug Deliv Rev. 2016. PMID: 27080735 Review.

10

Polymeric nanocapsules: a potential new therapy for corneal wound healing.

Reimondez-Troitiño S, Alcalde I, Csaba N, Íñigo-Portugués A, de la Fuente M, Bech F, Riestra AC, Merayo-Lloves J, Alonso MJ. Reimondez-Troitiño S, et al. Among authors: alonso mj. Drug Deliv Transl Res. 2016 Dec;6(6):708-721. doi: 10.1007/s13346-016-0312-0. Drug Deliv Transl Res. 2016. PMID: 27392604

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

407 results

Search Page